Literature DB >> 2402161

Idiopathic symptomatic osteoarthritis of the hip and knee: a population-based incidence study.

M G Wilson1, C J Michet, D M Ilstrup, L J Melton.   

Abstract

We identified all residents of Rochester, Minnesota, who sought medical assistance for the first time in 1985 because of symptomatic osteoarthritis of the hip or knee that was unrelated to a specific disease. Of these residents, 98 (59 women and 39 men) had 122 symptomatic joints (95 knees and 27 hips), for age- and sex-adjusted incidence rates of 205 new patients and 255 newly affected joints per 100,000 person-years. The incidence of osteoarthritis of the hip was greater in women than in men, whereas the sex ratio for occurrence of osteoarthritis of the knee approached unity. Rates at both sites increased steadily with aging in men but plateaued after the menopause in women; similar patterns were seen whether or not grade 1 disease was included. Projected nationally, these first population-based data indicate that as many as approximately half a million new symptomatic cases of idiopathic osteoarthritis of the knee and hip may arise annually in the white population of the United States. With increasing longevity, osteoarthritis may exact an even greater toll in the future.

Entities:  

Mesh:

Year:  1990        PMID: 2402161     DOI: 10.1016/s0025-6196(12)62745-1

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  36 in total

Review 1.  Role of bone architecture and anatomy in osteoarthritis.

Authors:  Julie C Baker-LePain; Nancy E Lane
Journal:  Bone       Date:  2012-01-24       Impact factor: 4.398

Review 2.  Prolotherapy in primary care practice.

Authors:  David Rabago; Andrew Slattengren; Aleksandra Zgierska
Journal:  Prim Care       Date:  2010-03       Impact factor: 2.907

3.  Definition of hip osteoarthritis for epidemiological studies.

Authors:  M C Nevitt
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

4.  Annual incidence rates of hip symptoms and three hip OA outcomes from a U.S. population-based cohort study: the Johnston County Osteoarthritis Project.

Authors:  A S Moss; L B Murphy; C G Helmick; T A Schwartz; K E Barbour; J B Renner; W Kalsbeek; J M Jordan
Journal:  Osteoarthritis Cartilage       Date:  2016-04-21       Impact factor: 6.576

Review 5.  Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care.

Authors:  G Peat; R McCarney; P Croft
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

6.  Ultrasound guided intra-articular ketorolac versus corticosteroid injection in osteoarthritis of the hip: a retrospective comparative study.

Authors:  Ki Deok Park; Tai Kon Kim; Byung Woo Bae; JaeKi Ahn; Woo Yong Lee; Yongbum Park
Journal:  Skeletal Radiol       Date:  2015-06-03       Impact factor: 2.199

Review 7.  Osteoarthritis and osteoporosis: what is the overlap?

Authors:  Irene E M Bultink; Willem F Lems
Journal:  Curr Rheumatol Rep       Date:  2013-05       Impact factor: 4.592

Review 8.  Prevalence of knee osteoarthritis in former athletes: a systematic review with meta-analysis.

Authors:  Fernanda O Madaleno; Bruna A Santos; Vanessa L Araújo; Vinicius C Oliveira; Renan A Resende
Journal:  Braz J Phys Ther       Date:  2018-04-04       Impact factor: 3.377

9.  Comparison of intra-articular injections of hyaluronic acid and corticosteroid in the treatment of osteoarthritis of the hip in comparison with intra-articular injections of bupivacaine. Design of a prospective, randomized, controlled study with blinding of the patients and outcome assessors.

Authors:  Sascha Colen; Michel P J van den Bekerom; Johan Bellemans; Michiel Mulier
Journal:  BMC Musculoskelet Disord       Date:  2010-11-16       Impact factor: 2.362

10.  Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis.

Authors:  Yvonne H Sniekers; Harrie Weinans; Gerjo J V M van Osch; Johannes P T M van Leeuwen
Journal:  Arthritis Res Ther       Date:  2010-10-05       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.